Venture capital investment in Mass.-headquartered biotech companies is returning to pre-COVID norms

A column chart showing, in blue, the venture capital investment (in billions of dollars) in Massachusetts-headquarters biotech companies from 2015–2025.

(Please use a modern browser to see the interactive version of this visualization)

Chart: DANA GERBER/GLOBE STAFFSource: Massachusetts Biotechnology Council